BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 29920789)

  • 21. Phase IV head-to-head randomized controlled trial comparing ingenol mebutate 0·015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp.
    Stockfleth E; Harwood CA; Serra-Guillén C; Larsson T; Østerdal ML; Skov T
    Br J Dermatol; 2018 Feb; 178(2):433-442. PubMed ID: 29030864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and tolerability of ingenol mebutate in the treatment of actinic keratosis.
    Berman B
    Expert Opin Drug Saf; 2015; 14(12):1969-78. PubMed ID: 26524598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of Efficacy and Irritation of Ingenol Mebutate Gel 0.015% Used With or Without Dimethicone Lotion for Treatment of Actinic Keratosis on the Face.
    Jim On SC; Hashim PW; Nia JK; Lebwohl MG
    J Drugs Dermatol; 2017 May; 16(5):432-436. PubMed ID: 28628678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized trial comparing simultaneous vs. sequential field treatment of actinic keratosis with ingenol mebutate on two separate areas of the head and body.
    Pellacani G; Peris K; Guillen C; Clonier F; Larsson T; Venkata R; Puig S
    J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2192-8. PubMed ID: 26300464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of actinic keratoses with 5% topical imiquimod: a multicenter prospective observational study from 93 Austrian office-based dermatologists.
    Strohal R; Kerl H; Schuster L
    J Drugs Dermatol; 2012 May; 11(5):574-8. PubMed ID: 22527424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survey of Patient Satisfaction With Ingenol Mebutate Gel Treatment for Actinic Keratosis From a Community Dermatology Practice.
    Schaefer D
    Skinmed; 2016; 14(4):259-265. PubMed ID: 27784514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of ingenol mebutate gel for actinic keratosis in patients in a community dermatology practice.
    Bettencourt MS
    J Drugs Dermatol; 2014 Mar; 13(3):269-73. PubMed ID: 24595570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ingenol mebutate gel for actinic keratosis.
    Lebwohl M; Swanson N; Anderson LL; Melgaard A; Xu Z; Berman B
    N Engl J Med; 2012 Mar; 366(11):1010-9. PubMed ID: 22417254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient-reported outcomes of topical therapies in actinic keratosis: A systematic review.
    Grada A; Feldman SR; Bragazzi NL; Damiani G
    Dermatol Ther; 2021 Mar; 34(2):e14833. PubMed ID: 33527673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the tolerability and safety of a 0.015% ingenol mebutate gel compared to 5% 5-fluorouracil cream for the treatment of facial actinic keratosis: a prospective randomized trial.
    Samorano LP; Torezan LA; Sanches JA
    J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1822-7. PubMed ID: 25727104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tracking actinic keratosis of face and scalp treated with 0.015% ingenol mebutate to identify clinical and dermoscopic predictors of treatment response.
    Pampena R; Benati E; Borsari S; Bombonato C; Lombardi M; Raucci M; Mirra M; Lallas A; Apalla Z; Papadimitriou I; Moscarella E; Kyrgidis A; Argenziano G; Pellacani G; Longo C
    J Eur Acad Dermatol Venereol; 2018 Sep; 32(9):1461-1468. PubMed ID: 29356164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of topical 3% diclofenac sodium gel and 5% imiquimod cream for the treatment of actinic keratoses.
    Akarsu S; Aktan S; Atahan A; Koç P; Özkan S
    Clin Exp Dermatol; 2011 Jul; 36(5):479-84. PubMed ID: 21418281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term clinical outcomes of imiquimod 5% cream vs. diclofenac 3% gel for actinic keratosis on the face or scalp: a pooled analysis of two randomized controlled trials.
    Gollnick H; Dirschka T; Ostendorf R; Kerl H; Kunstfeld R
    J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):82-89. PubMed ID: 31407414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the treatment costs and duration of topical treatments for multiple actinic keratosis based on the area of the cancerization field and not on the number of lesions.
    Calzavara-Pinton P; Tanova N; Hamon P
    J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):312-317. PubMed ID: 30288788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-efficacy analysis of 3% diclofenac sodium, ingenol mebutate, and 3.75% imiquimod in the treatment of actinic keratosis.
    Nisticò S; Del Duca E; Torchia V; Gliozzi M; Bottoni U; Muscoli C
    Int J Immunopathol Pharmacol; 2018; 32():2058738418757925. PubMed ID: 29442526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Resource Utilization and Treatment Patterns in Patients with Actinic Keratosis in the United States.
    Asche CV; Zografos P; Norlin JM; Urbanek B; Mamay C; Makin C; Erntoft S; Chen CC; Hines DM; Mark Siegel D
    Value Health; 2016; 19(2):239-48. PubMed ID: 27021759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of actinic keratoses and cancerization field of the face and scalp with 0.015% ingenol mebutate gel in Brazilian individuals: safety, tolerability and patients' perspectives.
    Gameiro L; Tovo LFR; Sanches Júnior JA; Aprahamian I
    An Bras Dermatol; 2019 Jul; 94(3):313-319. PubMed ID: 31365660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Daylight methyl-aminolevulinate photodynamic therapy versus ingenol mebutate for the treatment of actinic keratoses: an intraindividual comparative analysis.
    Genovese G; Fai D; Fai C; Mavilia L; Mercuri SR
    Dermatol Ther; 2016 May; 29(3):191-6. PubMed ID: 26799440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of topical imiquimod 3.75% in the treatment of actinic keratosis of the scalp in immunosuppressed patients: our case series.
    Zavattaro E; Veronese F; Landucci G; Tarantino V; Savoia P
    J Dermatolog Treat; 2020 May; 31(3):285-289. PubMed ID: 30836026
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of MAL-PDT, ingenol mebutate and diclofenac plus hyaluronate gel monitored by high-frequency ultrasound and digital dermoscopy in actinic keratosis - a randomized trial.
    Arisi M; Zane C; Polonioli M; Tomasi C; Moggio E; Cozzi C; Soglia S; Caravello S; Calzavara-Pinton I; Venturini M; Rossi MT; Calzavara-Pinton PG
    J Eur Acad Dermatol Venereol; 2020 Jun; 34(6):1225-1232. PubMed ID: 31793041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.